![A Faster, Simpler Liquid Biopsy Assay for Breast Cancer](https://www.g2intelligence.com/wp-content/uploads/2022/06/June27-2022.News_.Liquid-Biopsy-Breast-Cancer-iStock-1800x1250-1-1080x675.jpg)
A Faster, Simpler Liquid Biopsy Assay for Breast Cancer
Research team’s prototype test is easier to use than current methods and can detect cancer markers within 4.5 hours.
Research team’s prototype test is easier to use than current methods and can detect cancer markers within 4.5 hours.
The precision medicine company recently announced a pair of strategic alliances aimed at expanding access to new cancer diagnostics.
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
New research led by the American Cancer Society shows decreases in cervical and breast cancer screening during the pandemic.
A new AI method developed by the National Cancer Institute could produce results similar to regular CT scans, but without exposing patients to radiation.